Technical Analysis for CRL - Charles River Laboratories Intl

Grade Last Price % Change Price Change
C 357.38 -2.34% -8.5800
CRL closed down 2.34 percent on Friday, December 3, 2021, on 83 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical CRL trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish -2.34%
Crossed Above 200 DMA Bullish -2.34%
Lower Bollinger Band Touch Weakness -2.34%
Oversold Stochastic Weakness -2.34%
Fell Below 200 DMA Bearish -1.04%
Stochastic Reached Oversold Weakness -1.04%
Older End-of-Day Signals for CRL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Lower Bollinger Band 3 days ago
Down 3% 3 days ago
Down 1% 3 days ago
Down 2% 3 days ago
Fell Below 200 DMA 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Charles River Laboratories Intl Description

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification of a druggable target through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as bioanalysis, drug metabolism, pharmacokinetics, safety pharmacology, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Pharmaceutical Industry Life Sciences Biopharmaceutical Pharmacy Consumer Products Pharmacology Drug Discovery Vaccines Metabolism Diagnostic Products Vivo Biopharmaceuticals Diagnostic Product Pharmaceutical And Biotech Pathology Diagnostic Services Ggs Pharmaceutical And Biotechnology Biotechnology Companies Contract Research Organizations Kinetics Manufacturing Segment Toxicology Pharmacokinetics Assessment Services Drug Metabolism Safety Testing Services Bioanalysis Pathology Services

Is CRL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 460.21
52 Week Low 177.45
Average Volume 380,723
200-Day Moving Average 365.5936
50-Day Moving Average 401.5534
20-Day Moving Average 377.9570
10-Day Moving Average 370.3170
Average True Range 12.2909
ADX 30.25
+DI 12.7865
-DI 30.4417
Chandelier Exit (Long, 3 ATRs) 372.9173
Chandelier Exit (Short, 3 ATRs) 390.2327
Upper Bollinger Bands 398.3969
Lower Bollinger Band 357.5171
Percent B (%b) 0.0
BandWidth 10.8160
MACD Line -11.8800
MACD Signal Line -10.6430
MACD Histogram -1.2371
Fundamentals Value
Market Cap 17.78 Billion
Num Shares 49.7 Million
EPS 6.00
Price-to-Earnings (P/E) Ratio 59.59
Price-to-Sales 4.03
Price-to-Book 5.94
PEG Ratio 1.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 380.3150
Resistance 3 (R3) 381.5233 375.0867 376.4925
Resistance 2 (R2) 375.0867 369.2459 374.4825 375.2173
Resistance 1 (R1) 366.2333 365.6374 363.0150 365.0250 373.9437
Pivot Point 359.7967 359.7967 358.1875 359.1925 359.7967
Support 1 (S1) 350.9433 353.9559 347.7250 349.7350 340.8163
Support 2 (S2) 344.5067 350.3474 343.9025 339.5427
Support 3 (S3) 335.6533 344.5067 338.2675
Support 4 (S4) 334.4450